Anna-Lena Ungell

Title: Innovations in Thromboembolism Treatment by Anna-Lena Ungell

Introduction

Anna-Lena Ungell is a prominent inventor based in Göteborg, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of thromboembolism. With a total of 2 patents, her work is paving the way for new therapeutic options.

Latest Patents

Among her latest patents is a formulation for the treatment of thromboembolism. This innovative pharmaceutical formulation comprises the thrombin inhibitor HOOC—CH—(R)-Cgl-Aze-Pab in combination with medium chain glycerides. The patent details a process for the preparation of this formulation, its use in treating thromboembolism, and a method for treating patients in need of such treatment. Another notable patent is for an antithrombotic formulation, which includes the process for its manufacturing and use.

Career Highlights

Anna-Lena Ungell is currently associated with Astra Aktiebolag, a leading pharmaceutical company. Her work at Astra has allowed her to focus on developing groundbreaking treatments that address critical health issues.

Collaborations

She collaborates with Jan-Erik Löfroth, a fellow professional in the field, to enhance the research and development of her innovative formulations.

Conclusion

Anna-Lena Ungell's contributions to the pharmaceutical industry, particularly in thromboembolism treatment, highlight her role as a key innovator. Her patents reflect a commitment to advancing medical science and improving patient outcomes.